O. . Rikhsieva and N. Rajabova, “HIGH-COST ANTICANCER DRUGS: CLINICAL BENEFIT OR FINANCIAL BURDEN FOR THE HEALTHCARE SYSTEM?”, EJAR, vol. 5, no. 10(MPHAPP), p. 197, Oct. 2025.